Appeals court overturns damages in Zimmer Biomet’s $280M patent loss to Stryker

A federal appeals court overturned the triple damages and attorney fees awarded in Stryker’s $70 million patent infringement win over Warsaw’s own Zimmer Biomet, however its prior ruling that patents were valid and infringed was upheld.

The case was sent back to the U.S. Court of Appeals in June, when the Supreme Court held that the standard for enhanced damages awards in patent infringement cases should be relaxed.

The case dates back to December 2010, when Stryker sued it’s rival Zimmer, alleging infringement of 3 patents for wound debridement technology by Zimmer’s Pulsavac Plus device.